As described earlier, KRAS is one of the most frequently mutated oncogenes in human cancers, particularly in lung, colorectal, and pancreatic cancers.11KRAS mutations are most prevalent in patients with PDAC, followed by patients with CRC or NSCLC. This evidence concerns the gene KRAS and familial pancreatic carcinoma.